Showing results (271-280 of 363) with videos related to

Sort By:
Pageof 37
Journal of Diabetes and Metabolic Disorders|December 1, 2025
Validation and clinical usefulness of the SCORE2 cardiovascular risk prediction algorithms in an Iranian populationEhsan Shahrestanaki, Masoud Solaymani-Dodaran, Morteza Mohammadzadeh, et al.
Annals of Saudi Medicine|June 5, 2014
Distribution of ideal cardiovascular health in a community-based cohort of Middle East populationMariam Maleki Moghaddam, Reza Mohebi, Firoozeh Hosseini, et al.
Journal of Hypertension|February 21, 2022
Application of the 2017 American college of cardiology/American Heart Association Blood Pressure Guidelines for cardiovascular outcomes among Tehranian residentsSeyed Saeed Tamehri Zadeh, Seyyed Saeed Moazzeni, Kunihiro Matsushita, et al.
Cardiovascular Diabetology|December 3, 2022
Changes in Fasting plasma glucose status and risk of mortality events in individuals without diabetes over two decades of Follow-up: a pooled cohort analysisKarim Kohansal, Soroush Masrouri, Davood Khalili, et al.
Nutrition & Metabolism|July 17, 2018
Impact of 3-year changes in lipid parameters and their ratios on incident type 2 diabetes: Tehran lipid and glucose studyPegah Khaloo, Mitra Hasheminia, Maryam Tohidi, et al.
Preventive Medicine|October 11, 2012
Change in general and central adiposity measures in prediction of incident dysglycemia; Tehran Lipid and Glucose StudyFarzad Hadaegh, Younes Jahangiri Noudeh, Maryam Tohidi, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 10, 2025
Trajectories of Lipid Profile During Adolescence and Risk of Subclinical Atherosclerosis in Early Adulthood: A Two-Decade Population-Based StudyFarzad Esmaeili, Maryam Tohidi, Davood Khalili, et al.
BMC Public Health|October 7, 2020
Sex-specific prevalence of coronary heart disease among Tehranian adult population across different glycemic status: Tehran lipid and glucose study, 2008-2011Seyyed Saeed Moazzeni, Hamidreza Ghafelehbashi, Mitra Hasheminia, et al.
Clinical Biochemistry|March 25, 2014
Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose StudyAmirahmad Nejat, Mohammadhassan Mirbolouk, Reza Mohebi, et al.
BMC Cardiovascular Disorders|October 18, 2024
Optimal risk thresholds for prescribing statins as primary prevention of cardiovascular disease in Iranian general population: a benefit-harm modelling studyDavood Khalili, Hassan Saadati, Hamid Reza Baradaran, et al.
Pageof 37